EUVIMEDOpdag EUVIMED
Crossref

Covalently crosslinked chitosan–astaxanthin nanoparticles: a stable, bioavailable oral delivery system with potentiated relief efficacy against chronic colitis

Xinwei Gong iD, Huiru Li, Lu Yang iD, Chuqiao Zhang, Hongxia Che, Yuchao Gu, Hongyan Li iD

Journal of the Science of Food and Agriculture · 2026

DOI: 10.1002/jsfa.70895 ↗

At a glance

Journal article in Journal of the Science of Food and Agriculture, 2026. Written by Xinwei Gong and 6 co-authors. Institution: College of Biological Engineering, Shandong Provincial Key Laboratory of Biochemical Engineering, Qingdao University of Science and Technology, Qingd…. Major MEDLINE topics: Colitis, Chitosan, Nanoparticles, Anti-Inflammatory Agents. 72 references. Funded by: The research was supported by the Qingdao Marine Science and Technology Center (No. 8-01 and 2022QNLM030003-4), the Taishan Scholars Program (No. tsqn202211058….

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

BACKGROUND Astaxanthin (AST) has potent antioxidant and anti‐inflammatory properties; however, it is unstable and easily oxidized. RESULTS In this study, chitosan (CS) was employed to stabilize AST through covalent crosslinking to synthesize chitosan–astaxanthin (CS–AST) complex, and then self‐assembled into chitosan–astaxanthin nanoparticles (CS–ASTNPs). CS–ASTNPs showed a smooth, spherical morphology with a particle size of 102.6 ± 1.3 nm. The hydrodynamic particle size was 141.8 ± 1.7 nm with a zeta potential of 30.5 ± 1.4 mV. The encapsulation efficiency and loading capacity of AST within CS–ASTNPs were 83.6% and 46.1%, respectively. In a chronic colitis model induced by dextran sulfate sodium (DSS), CS–ASTNPs significantly improved the symptoms in mice body weight, colon length, and disease activity index (DAI) scores caused by DSS. The colon barrier was enhanced through increasing the level of the proteins ZO‐1, occludin, and MUC2. Furthermore, the overproduction of pro‐inflammatory cytokines tumor necrosis factor alpha (TNF‐α) and interleukin 1 beta (IL‐1β), and the proteins NLRP3, ASC, Caspase‐1, GSDMD, and cleaved Caspase‐1 were reduced, while the anti‐inflammatory cytokine interleukin 10 (IL‐10) increased. The oxidative response in colon tissues was suppressed via regulating the Nrf2/HO‐1 pathway. Additionally, CS–ASTNPs increased the Bacteroidetes/Firmicutes ratio and elevated the richness of beneficial bacteria norank_f__Muribaculaceae , Lactobacillus , and Akkermansiaceae . Notably, CS–ASTNPs showed significantly greater improvement than CS + AST ( P < 0.05). CONCLUSION In sum, CS–ASTNPs has significant potential for development as a functional food or as a drug for treating colitis. © 2026 Society of Chemical Industry.

Subjects

MeSH terms (MEDLINE)

ColitisChitosanNanoparticlesAnti-Inflammatory AgentsDrug Delivery SystemsAnimalsMiceXanthophyllsHumansAdministration, OralDrug CarriersDextran SulfateTumor Necrosis Factor-alphaMaleColonBiological AvailabilityChronic DiseaseInterleukin-1betaParticle SizeMice, Inbred C57BL

Author keywords

Nrf2/HO‐1 pathwaychitosan–astaxanthin nanoparticleschronic colitisgut microbiotainflammatory responseintestinal barrier

Substances

ChitosanXanthophyllsastaxanthineAnti-Inflammatory AgentsDrug CarriersDextran SulfateTumor Necrosis Factor-alphaInterleukin-1beta

Authors and institutions

  • College of Biological Engineering, Shandong Provincial Key Laboratory of Biochemical Engineering, Qingdao University of Science and Technology, Qingdao, China.
  • College of Food Science and Engineering, Qingdao Agricultural University, Qingdao, China.

ORCID profiles: Xinwei Gong, Lu Yang, Hongyan Li

Funding

  • The research was supported by the Qingdao Marine Science and Technology Center (No. 8-01 and 2022QNLM030003-4), the Taishan Scholars Program (No. tsqn202211058…

Cite

APA

Gong, X., Li, H., Yang, L., Zhang, C., Che, H., Gu, Y., & Li, H. (2026). Covalently crosslinked chitosan–astaxanthin nanoparticles: a stable, bioavailable oral delivery system with potentiated relief efficacy against chronic colitis. Journal of the Science of Food and Agriculture. https://doi.org/10.1002/jsfa.70895

Vancouver

Gong X, Li H, Yang L, Zhang C, Che H, Gu Y, et al. Covalently crosslinked chitosan–astaxanthin nanoparticles: a stable, bioavailable oral delivery system with potentiated relief efficacy against chronic colitis. Journal of the Science of Food and Agriculture. 2026. doi:10.1002/jsfa.70895

BibTeX
@article{Gong2026,
  author = {Gong, Xinwei and Li, Huiru and Yang, Lu and Zhang, Chuqiao and Che, Hongxia and Gu, Yuchao and Li, Hongyan},
  title = {Covalently crosslinked chitosan–astaxanthin nanoparticles: a stable, bioavailable oral delivery system with potentiated relief efficacy against chronic colitis},
  journal = {Journal of the Science of Food and Agriculture},
  year = {2026},
  doi = {10.1002/jsfa.70895}
}
Start for free →